ACM Research (NASDAQ: ACMR) completes 2,884,615-share sale at $52.00
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
ACM Research, Inc. completed a registered direct stock offering of 2,884,615 shares of Class A common stock at $52.00 per share under an effective Form S-3 shelf registration. The transaction closed on May 15, 2026, and the company received approximately $149,849,980 in net proceeds after estimated expenses.
Positive
- None.
Negative
- None.
Insights
ACM Research completed a sizable direct equity raise, strengthening liquidity while adding share dilution.
ACM Research issued 2,884,615 Class A common shares at $52.00 per share in a registered direct offering to institutional investors using its Form S-3 shelf. The deal was executed quickly, with the purchase agreement on May 12, 2026 and closing on May 15, 2026.
The company received approximately $149,849,980 in net proceeds after offering expenses, which increases available capital but also expands the share count. The filing does not specify the planned use of funds, so future disclosures in company communications or periodic reports may provide context on how this capital supports operations or growth initiatives.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Shares issued: 2,884,615 shares
Offering price: $52.00 per share
Net proceeds: $149,849,980
+3 more
6 metrics
Shares issued
2,884,615 shares
Class A common stock sold in registered direct offering
Offering price
$52.00 per share
Price for each share of Class A common stock
Net proceeds
$149,849,980
Approximate net cash received after estimated expenses
Registration form
Form S-3 (File No. 333-278041)
Shelf registration statement used for the offering
Agreement date
May 12, 2026
Date of Securities Purchase Agreement with investors
Closing date
May 15, 2026
Date the registered direct offering was consummated
Key Terms
registered direct offering, Securities Purchase Agreement, shelf registration statement, Form S-3, +2 more
6 terms
registered direct offering financial
"the Company agreed to issue and sell to the Investors in a registered direct offering (the “Offering”)"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Securities Purchase Agreement financial
"ACM Research, Inc. entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
shelf registration statement regulatory
"at an offering price of $52.00 per Share pursuant to an effective shelf registration statement on Form S-3"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
Form S-3 regulatory
"pursuant to an effective shelf registration statement on Form S-3 (File No. 333-278041)"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
prospectus supplement regulatory
"and a related prospectus supplement filed with the U.S. Securities and Exchange Commission on May 12, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Item 8.01 Other Events regulatory
"Item 8.01 Other Events. As previously disclosed, on May 12, 2026, ACM Research, Inc."
FAQ
What did ACM Research (ACMR) announce in its latest 8-K filing?
ACM Research reported completion of a registered direct offering of 2,884,615 Class A common shares at $52.00 per share. The transaction used an effective Form S-3 shelf registration and closed on May 15, 2026 with net proceeds of approximately $149,849,980.
How much cash did ACM Research (ACMR) raise from this stock sale?
ACM Research received approximately $149,849,980 in net proceeds from the registered direct offering. This figure reflects total cash raised after deducting estimated offering expenses the company is responsible for paying in connection with the transaction.
What registration statement did ACM Research (ACMR) use for this offering?
The company used an effective shelf registration statement on Form S-3, File No. 333-278041, together with a related prospectus supplement filed May 12, 2026. These documents allowed ACM Research to conduct the registered direct offering of its Class A common stock.
When did ACM Research (ACMR) complete its registered direct offering?
ACM Research consummated the registered direct offering on May 15, 2026. This closing followed execution of the Securities Purchase Agreement on May 12, 2026 and filing of the related prospectus supplement under the company’s effective Form S-3 shelf registration.